← Back to Search
Design, Synthesis, And Evaluation Of A Water-soluble Antofine Analogue With High Antiproliferative And Antitumor Activity.
Yongseok Kwon, J. Song, Boeun Lee, Jinkyung In, H. Song, H. Chung, S. Lee, S. Kim
Published 2013 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
New water soluble antofine C-13a analogues were designed, synthesized, and evaluated for antiproliferative activity against cancer cells. Particularly, (-)-(R)-13a-hydroxymethylantofine ((-)-(R)-4b) demonstrated notable growth inhibition against a panel of human cancer cell lines. This growth inhibition was associated with the arrest of the cell cycle in the G0/G1 phases and suppression of mTOR signaling in human lung A549 cancer cells. Compound (-)-(R)-4b also overcame paclitaxel-resistance in human lung cancer cells (A549-Pa) by suppressing P-glycoprotein expression. Furthermore, compound (-)-(R)-4b significantly inhibited the tumor growth of A549 and A549-Pa xenografts in a nude mouse model, which suggests it is a promising novel antitumor agent with sufficient aqueous solubility.
This paper references
Online early access
Y.-J. Kang (2012)
Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.
W. Gao (2007)
In vitro cytotoxic activity of phenanthroindolizidine alkaloids from Cynanchum vincetoxicum and Tylophora tanakae against drug-sensitive and multidrug-resistant cancer cells.
D. Staerk (2002)
Pharmacological investigations of tylophorine, the major alkaloid of Tylophora indica.
C. Gopalakrishnan (1979)
Enantioselective total synthesis of avrainvillamide and the stephacidins.
P. Baran (2006)
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
X. Yang (2011)
Cancer Statistics, 2010
A. Jemal (2010)
Structure-brain exposure relationships.
S. Hitchcock (2006)
Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.
Minoru Ishikawa (2011)
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
T. Chou (2006)
Growth inhibition of human lung cancer cells via down-regulation of epidermal growth factor receptor signaling by yuanhuadine, a daphnane diterpene from Daphne genkwa.
J. Hong (2011)
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies.
X. Yang (2012)
Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
T. Ikeda (2011)
Upstream and downstream of mTOR.
N. Hay (2004)
Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo.
M. Leggas (2006)
Alkaloids: Chemical and Biological Perspectives, vol. 2
Y. Shimizu (1985)
Expedient synthesis and structure-activity relationships of phenanthroindolizidine and phenanthroquinolizidine alkaloids.
Ta-Hsien Chuang (2006)
Efficient Synthesis of Aza-Phenanthroindolizidine and Aza-Phenanthroquinolizidine and Anticancer Activities
K. Wang (2008)
Alkylation of amino acids without loss of the optical activity: preparation of .alpha.-substituted proline derivatives. A case of self-reproduction of chirality
D. Seebach (1983)
Anticancer agents based on natural product models
J. M. Cassady (1980)
Total synthesis of phenanthroindolizidine alkaloids (+/-)-antofine, (+/-)-deoxypergularinine, and their dehydro congeners and evaluation of their cytotoxic activity.
Chung-Ren Su (2008)
Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques
A. Avdeef (2002)
Isolation, Total Synthesis and Biological Activity of Phenanthroindolizidine and Phenanthroquinolizidine Alkaloids
Z. Li (2004)
Detection of activity of P‐glycoprotein in human tumour samples using rhodamine 123
C. Ludescher (1992)
Gefitinib: a review of its use in the management of advanced non-small-cell lung cancer.
J. Frampton (2004)
Phenanthroindolizidines and Phenanthroquinolizidines: Promising Alkaloids for Anti-Cancer Therapy.
S. Chemler (2009)
Suppression of Prostaglandin E2-Mediated Cell Proliferation and Signal Transduction by Resveratrol in Human Colon Cancer Cells
S. Song (2010)
Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells.
T. Kitazaki (2005)
Synthesis and structure-activity studies of antofine analogues as potential anticancer agents.
Ye Fu (2007)
Selective Drug Resistant Human Osteosarcoma Cell Lines
B. Burns (2001)
First asymmetric total synthesis of (-)-antofine by using an enantioselective catalytic phase transfer alkylation.
S. Kim (2003)
Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica.
S. Lee (1998)
Caught up in a Wnt storm: Wnt signaling in cancer.
R. Giles (2003)
Multidrug Resistance Phenotype and Paclitaxel (Taxol®) Sensitivity in Human Renal Carcinoma Cell Lines of Different Histologic Types
P. Reinecke (2000)
Lost in translation: dysregulation of cap-dependent translation and cancer.
Mary-Ann Bjornsti (2004)
Enantioselective approach to 13a-methylphenanthroindolizidine alkaloids.
Bo Su (2012)
Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration.
D. E. Clark (1999)
Cytotoxic activity and G2/M cell cycle arrest mediated by antofine, a phenanthroindolizidine alkaloid isolated from Cynanchum paniculatum.
S. Lee (2003)
Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells.
E. Kim (2012)
Wnt/β-Catenin Signaling Mediates the Antitumor Activity of Magnolol in Colorectal Cancer Cells
Y. Kang (2012)
Synthesis and evaluation of cytotoxicity of stilbene analogues
S. Lee (2003)
The Indolizidine Alkaloids
E. Gellert (1982)
4-Alkyl-2-trichloromethyloxazolidin-5-ones: Valuable Precursors to Enantiomerically Pure C- and N-Protected α-Alkyl Prolines
H. Wang (1999)
This paper is referenced by
Antofine, a natural phenanthroindolizidine alkaloid, suppresses angiogenesis via regulation of AKT/mTOR and AMPK pathway in endothelial cells and endothelial progenitor cells derived from mouse embryonic stem cells.
J. Oh (2017)
Synthesis and characterization of phenanthrene derivatives for optoelectronic applications
Sondes Raouafi (2017)
In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells
J. Liu (2017)
Gold-catalyzed 6-exo-dig cycloisomerization: a versatile approach to functionalized phenanthrenes.
C. Shu (2014)
Antitumor activity of phenanthroindolizidine alkaloids is associated with negative regulation of Met endosomal signaling in renal cancer cells.
J. Song (2015)
The potential impacts of tylophora alkaloids and their derivatives in modulating inflammation, viral infections, and cancer.
D. Bach (2018)
Synthesis of (–)‐Cryptopleurine by Combining Gold(I) Catalysis with a Free Radical Cyclization
Alexander Stoye (2015)
Enantioselective Synthesis of (R)‐Antofine and (R)‐Cryptopleurine
Anas Ansari (2018)
Iron-catalyzed tandem carbon–carbon/carbon–oxygen bond formation/aromatization of 2′-alkynyl-biphenyl-2-carbinols: a new approach to the synthesis of substituted phenanthrenes
Krishnendu Bera (2015)
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
Yongseok Kwon (2015)
Biologically active indolizidine alkaloids
Junmin Zhang (2020)